Formycon AG
XETRA:FYB

Watchlist Manager
Formycon AG Logo
Formycon AG
XETRA:FYB
Watchlist
Price: 43 EUR 1.06% Market Closed
Updated: May 30, 2024

Formycon AG
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Formycon AG
Operating Income Peer Comparison

Comparables:
BNTX
MOR
CVAC
IMTX
BIO

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Formycon AG
XETRA:FYB
Operating Income
-€369k
CAGR 3-Years
62%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
Operating Income
€908m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Operating Income
-€440.4m
CAGR 3-Years
-30%
CAGR 5-Years
-58%
CAGR 10-Years
N/A
CureVac NV
NASDAQ:CVAC
Operating Income
-€269.7m
CAGR 3-Years
-35%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Immatics NV
NASDAQ:IMTX
Operating Income
-€101.7m
CAGR 3-Years
-13%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Operating Income
€196.3m
CAGR 3-Years
N/A
CAGR 5-Years
102%
CAGR 10-Years
14%

See Also

What is Formycon AG's Operating Income?
Operating Income
-369k EUR

Based on the financial report for Dec 31, 2023, Formycon AG's Operating Income amounts to -369k EUR.

What is Formycon AG's Operating Income growth rate?
Operating Income CAGR 3Y
62%

Over the last year, the Operating Income growth was 98%. The average annual Operating Income growth rates for Formycon AG have been 62% over the past three years .